Conatus Pharmaceuticals

Get Full Access

Description

  • We are a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. Our lead compound, emricasan, is a first-in-class, orally active pan-caspase protease inhibitor designed to reduce the activity of human caspases, which are enzymes that mediate inflammation and apoptosis. We believe that by reducing the activity of these enzymes, emricasan has the potential to interrupt the progression of liver disease and potentially provide treatment options in multiple areas of liver disease.We have observed compelling preclinical and clinical trial results that suggest emricasan may have clinical utility in slowing progression of liver disease regardless of the original cause of the disease. To date, emricasan has been studied in over 650 subjects in sixteen clinical trials across a broad range of liver disease etiologies and stages of progression. In multiple clinical trials, emricasan has demonstrated statistically significant, consistent, rapid and sustained reduction in elevated levels of key biomarkers of inflammation and apoptosis implicated in the severity and progression of liver disease. Importantly, these key biomarkers are known to be elevated and to have prognostic value in multiple hepatic indications that we are currently pursuing.In December 2016, Conatus announced an exclusive option, collaboration and license agreement with Novartis for the global development and commercialization of emricasan.
  • location

    Headquarters:16745 W Bernardo Dr Ste 250 Suite 200, San Diego, California, United States

    More
  • Conatus Pharmaceuticals phone

    Phone Number: +1 858-376-2600

  • Conatus Pharmaceuticals website

    Website: https://www.conatuspharma.com

  • Conatus Pharmaceuticals employees

    Employees:26

  • Conatus Pharmaceuticals revenue

    Revenue:$1 - 10M

  • Conatus Pharmaceuticals legal name

    Legal Name:Conatus Pharmaceuticals

  • Conatus Pharmaceuticals's Social Media

    Conatus Pharmaceuticals linkedin
  • done Is this data correct?
  • |  NAICS Code: 621111  |

    Show More
Person level website identification

Senior Vice President And Chief Financial Officer for Conatus Pharmaceuticals

Charles Cashion

Senior Vice President And Chief Financial Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Charles Cashion

Senior Vice President And Chief Financial Officer

Mira Huyghe

Vice President Clinical Devt

Patricia Gladstone

Vice President, Regulatory Affairs And Cmc

Frequently Asked Questions regarding Conatus Pharmaceuticals

  • Where are Conatus Pharmaceuticals's Headquarters?

    Conatus Pharmaceuticals's Headquarters are in 16745 W Bernardo Dr Ste 250 Suite 200,San Diego,California,United States

  • What is Conatus Pharmaceuticals's phone number?

    Conatus Pharmaceuticals's phone number is +1 858-376-2600

  • What is Conatus Pharmaceuticals's official website?

    Conatus Pharmaceuticals's official website is https://www.conatuspharma.com

  • What is Conatus Pharmaceuticals's Revenue?

    Conatus Pharmaceuticals's revenue is $1 - 10M

  • What is Conatus Pharmaceuticals's NAICS code?

    Conatus Pharmaceuticals's NAICS code is 621111

  • How many employees are working in Conatus Pharmaceuticals

    Conatus Pharmaceuticals has 26 employees

  • What is Conatus Pharmaceuticals's Industry?

    Conatus Pharmaceuticals is in the industry of Biotechnology

  • Who is Conatus Pharmaceuticals's Senior Vice President And Chief Financial Officer?

    Conatus Pharmaceuticals's Senior Vice President And Chief Financial Officer is Charles Cashion

Company Directory